Sadly holders in OPT have had bad news today. Perhaps they come on board on EYE at these basement levels and recoup something soon. EYE has a FDA approved product and we are told is gaining market share. The 2RT interest might encourage or dissuade them. Sorry for the investors there including Analyst007. I hope he comes good with EYE.
JHX Price at posting:
$41.04 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)